메뉴 건너뛰기




Volumn 13, Issue 5, 2007, Pages 296-297

Are anti-TNFα therapies too good? An audit of patients' compliance

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTAGONIST; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR;

EID: 35148874201     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181581b51     Document Type: Article
Times cited : (2)

References (4)
  • 1
    • 10944229392 scopus 로고    scopus 로고
    • Does safety make a difference in selecting the right TNFα antagonist?
    • Fleishmann R, Yocum D. Does safety make a difference in selecting the right TNFα antagonist? Arthritis Res Ther. 2004;6(Suppl 2):S12-S18.
    • (2004) Arthritis Res Ther , vol.6 , Issue.SUPPL. 2
    • Fleishmann, R.1    Yocum, D.2
  • 2
    • 27744458586 scopus 로고    scopus 로고
    • Infections in patients with rheumatoid arthritis treated with biologic agents
    • Listing J, Strangfeld A, Kary S, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005;52:3403-3412.
    • (2005) Arthritis Rheum , vol.52 , pp. 3403-3412
    • Listing, J.1    Strangfeld, A.2    Kary, S.3
  • 3
    • 14044260093 scopus 로고    scopus 로고
    • Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis
    • Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44:157-163.
    • (2005) Rheumatology , vol.44 , pp. 157-163
    • Ledingham, J.1    Deighton, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.